Genomic Analyses of SLAMF7 CAR-T Cells Manufactured by Sleeping Beauty Transposon Gene Transfer for Immunotherapy of Multiple Myeloma
C. Miskey, M. Amberger, M. Reiser, S. Prommersberger, J. Beckmann, M. Machwirth, H. Einsele, M. Hudecek, H. Bonig, Z. Ivics
This paper characterizes the genomic safety of SLAMF7 CAR-T cells produced using Sleeping Beauty transposon technology for multiple myeloma treatment, showing safe integration and no residual transposase.
bioRxiv · Aug 27, 2019 · PreprintBioengineering